Cargando…
Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin
Pancreatic cancer is the fourth most common cause of cancer mortality worldwide. Furthermore, patients with pancreatic cancer experience limited benefit from current chemotherapeutic approaches because of drug resistance. Therefore, an effective therapeutic strategy for patients with pancreatic canc...
Autores principales: | Xu, Xiao Dong, Zhao, Yan, Zhang, Min, He, Rui Zhi, Shi, Xiu Hui, Guo, Xing Jun, Shi, Cheng Jian, Peng, Feng, Wang, Min, Shen, Min, Wang, Xin, Li, Xu, Qin, Ren Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343905/ https://www.ncbi.nlm.nih.gov/pubmed/28208617 http://dx.doi.org/10.3390/ijms18020370 |
Ejemplares similares
-
Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells
por: Yang, Yan-li, et al.
Publicado: (2013) -
Deguelin Suppresses Pancreatic Tumor Growth and Metastasis by Inhibiting Epithelial to Mesenchymal Transition in an Orthotopic Model()
por: Boreddy, Srinivas Reddy, et al.
Publicado: (2012) -
Stereocontrolled semi-syntheses of deguelin and tephrosin
por: Russell, David A., et al.
Publicado: (2017) -
Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells
por: LI, ZHENGGUANG, et al.
Publicado: (2014) -
Akt inhibitor deguelin aggravates inflammation and fibrosis in myocarditis
por: Li, Shanshan, et al.
Publicado: (2019)